Investing.com - Morphosys AG reported on Wednesday second quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Morphosys AG announced earnings per share of €-6.88 on revenue of €59.4M. Analysts polled by Investing.com anticipated EPS of €-2.02 on revenue of €57.95M.
Morphosys AG shares are down 31% from the beginning of the year, still down 55.79% from its 52 week high of €51.60 set on September 3, 2021. They are under-performing the STOXX 600 which is down 10.15% from the start of the year.
Morphosys AG follows other major Healthcare sector earnings this month
Morphosys AG's report follows an earnings missed by Siemens Healthineers on Wednesday, who reported EPS of €0.43 on revenue of €5.19B, compared to forecasts EPS of €0.4789 on revenue of €5.05B.
Sartorius AG VZO had matched expectations on July 21 with second quarter EPS of €2.44 on revenue of €1.04B, compared to forecast for EPS of €2.44 on revenue of €1.04B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar